Klimova, N., Long, A
100% pure L-Carnitine at a pharmaceutical grade capacity
Can GLP-1 Agonists Be Given Along with Intermittent Fasting
Costanza Alciati, a pharma analyst at GlobalData, told BioSpace in an email that GLP-1s will definitely dominate the market in the near future, but new entrants into the space are already looking for the next drug class that could revolutionize the space. Companies taking an alternative approach are forecast to capture only a very small portion of the obesity marketroughly 6.3%across the seven major markets (U.S., France, Germany, Italy, Spain, UK and Japan) by the end of 2031, according to Sara Reci, a senior analyst at GlobalData
For some genes, the Broad Institute database gives more than one value and they are averaged in the tables
A.AlrumaihiF.AlmatroudiA.AljasirM.et al (2022)